Table 1.
Baseline clinical characteristics, vascular risk factors, stroke subtype, biochemical parameters and neuroimaging findings in patients with good or poor outcome at 12 ± 3 months
| Good outcome n = 351 | Poor outcome n = 201 | p value | |
|---|---|---|---|
| Age, years | 66.9 ± 11.6 | 69.6 ± 9.4 | 0.001 |
| Males, % | 61.3 | 63.7 | 0.586 |
| History of hypertension, % | 58.4 | 71.6 | 0.002 |
| History of diabetes, % | 19.4 | 27.9 | 0.026 |
| Smoking habit, % | 26.8 | 13.4 | < 0.0001 |
| Alcohol consumption, % | 15.4 | 9.5 | 0.051 |
| History of hyperlipidemia, % | 41.3 | 55.2 | 0.002 |
| History of ischemic heart disease, % | 15.4 | 16.9 | 0.631 |
| History of atrial fibrillation, % | 24.8 | 34.8 | 0.014 |
| History of heart failure, % | 10.3 | 9.5 | 0.883 |
| Previous disability (mRS < 1) | 0 (0, 0) | 0 (0, 0) | 0.448 |
| Statins prior to stroke, % | 31.3 | 21.1 | 0.008 |
| Axillary temperature admission, °C | 36.4 ± 0.5 | 36.6 ± 0.5 | 0.080 |
| Glucose levels, mg/dL | 127.6 ± 50.4 | 143.2 ± 43.5 | < 0.0001 |
| Leukocytes, × 103/mmc | 9.3 ± 6.1 | 9.1 ± 2.4 | 0.100 |
| Fibrinogen, mg/dL | 404.7 ± 133.4 | 439.6 ± 160.1 | 0.003 |
| NIHSS at admission | 8 (5, 13) | 18 (14, 20) | < 0.0001 |
| Fibrinolytic treatment, % | 39.0 | 30.3 | 0.043 |
| Infarct volume (4th to 7th day), mL | 16.8 ± 29.8 | 98.2 ± 94.1 | < 0.0001 |
| Hemorrhagic transformation, % | 13.4 | 16.9 | 0.263 |
| Statins after stroke, % | 70.9 | 62.2 | 0.038 |
| TOAST | 0.113 | ||
| Atherothrombotic, % | 11.7 | 17.9 | |
| Cardioembolic, % | 48.1 | 53.2 | |
| Indeterminate, % | 40.2 | 28.9 | |
| Rehabilitation during-hospital, % | 27.1 | 33.0 | 0.145 |
| Rehabilitation during 12 months, % | 10.3 | 18.9 | 0.007 |